HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

PBM Capital Group Acquires Breas Medical

By HospiMedica International staff writers
Posted on 17 Feb 2014
GE Healthcare (Little Chalfont, United Kingdom) has sold Breas Medical (Mölnlycke, Sweden), its manufacturer of sleep apnea and respiratory ventilators, to PBM Capital Group (Charlottesville, VA, USA) for an undisclosed price.

The Swedish manufacturer will be integrated into PBM Capital's Human Design Medical (HDM) arm, a lifestyle medical device company that focuses on the treatment of sleep apnea. The acquisition of Breas will allow HDM to market the Z1 CPAP machine—a lightweight, portable ventilator which has become the fastest-growing sleep apnea device in the world—internationally, taking advantage of Breas Medical’s presence in more than 40 countries. Breas, on the other hand, will help PBM develop new products and enter the US market, a space it did not previously occupy.

“We acquired Breas because it is a logical fit with our growing HDM sleep apnea business,” said Paul B. Manning, CEO of PBM Capital. “The Z1 CPAP machine has had an incredible launch here in the United States, and we have more innovative products in the pipeline. The Breas acquisition opens the door to global distribution channels and gives us immediate access to an established line of home care ventilators backed by a strong IP portfolio. We are very excited to merge these two great companies.”

“The Breas management team is excited with this transaction and looks forward to leveraging our core efficient operation developed by GE Healthcare, our strong customer relationships, and significant global breadth with an entrepreneurial owner that is focused on changing the respiratory industry,” said Nicke Svanvik, CEO of Breas.

PBM Capital Group is a private investment firm focused on healthcare and life science investments across all stages of corporate development—venture capital, leveraged buyouts, growth capital, distressed/turnaround, and public equity value investing. Portfolio companies also include PBM Pharmaceuticals, Enzymatics, Triangle Research Labs, Firefly BioWorks, Gen 9, and QC Labs.

Related Links:

GE Healthcare
Breas Medical
PBM Capital Group



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Total Ankle Prosthesis
SALTO TALARIS
New
Auditory Evoked Potential Device
Bio-logic NavPRO ONE

Latest Business News

Expanded Collaboration to Transform OR Technology Through AI and Automation

Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business

Boston Scientific Acquires Medical Device Company SoniVie